Law Offices of Thomas J. Lamb

  • Free Case Evaluation
  • Mesothelioma & Asbestos Diseases
  • Legal Compensation
  • Asbestos Overview
  • Common Questions
  • About Our Firm

Disappointment Over Immunotherapy in Mesothelioma

November 19, 2019 By Thomas Lamb

Despite showing promise in phase 2 trials, new results from a randomized phase 3 [ immunotherapy in mesothelioma ] trial are disappointing in a tumor type that remains a major killer.

In patients with malignant pleural mesothelioma (MPM) who had progressed after first-line chemotherapy, immunotherapy with pembrolizumab (Keytruda, Merck) appears to offer no survival advantages over standard chemotherapy.

The results come from the PROMISE-meso study, presented here at the European Society of Medical Oncology (ESMO) annual meeting.

Despite “nearly four times more patients” responding to immunotherapy than standard chemotherapy, “unfortunately these responses did not delay progression or improve survival,” noted study investigator Sanjay Popat, MD, PhD, thoracic medical oncologist, Royal Marsden Hospital NHS Foundation Trust, London, England.

However, while pembrolizumab “was not superior to chemotherapy, survival was similar, and so pembrolizumab may represent an alternative.”

He highlighted that, as in other immunotherapy trials in other cancer types, some of the mesothelioma patients had long responses, which suggests that some patients could “preferentially receive this treatment over chemotherapy.”

Popat also suggested that, learning a lesson from lung cancer trials, combining immunotherapy with chemotherapy could have a beneficial effect.

“I would advise clinicians to enroll their patients into one of the large ongoing trials of first-line combination treatment so we can get answers as soon as possible about how to improve mesothelioma treatment,” he said.

[Article continues at original source]


 Asbestos & Mesothelioma Information

  Asbestos-Mesothelioma Case Evaluation
Free.  Confidential.  No Obligation.

Filed Under: Uncategorized

Do I Have A Possible Case?

If you have a possible asbestos disease or mesothelioma lawsuit, you can get a free, confidential, and no obligation case review from asbestos lawyer Tom Lamb.

Main Navigation Menu

  • Who Was Exposed to Asbestos
  • NC Asbestos Exposure Sites
  • Asbestos-Contaminated Talc
  • Asbestos Diseases
  • Legal Compensation
  • Free Case Evaluation
  • Frequently Asked Questions
  • About Our Law Firm
  • Attorney Tom Lamb
  • Collection of Articles
  • Sitemap

Attorney Tom Lamb

TJL@LambLawOffice.com

Phone: 800-426-9535

Lumina Station, Suite 225
1908 Eastwood Road
Wilmington, North Carolina

Please know that you can use our Quick Contact Form to tell us about your case.

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Website

Lamb Law Office

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Disclaimer and Copyright Notices
  • Sitemap

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.